Dyslipidemias Have a Detrimental Effect on Left Ventricular Systolic Function in Patients With a First Acute Myocardial Infarction
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference21 articles.
1. Randomised trial of cholesterol lowering therapy in 4444 patients with coronary heart disease;Lancet,1994
2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995
3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996
4. Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B;Brown;N Engl J Med,1990
5. The effect of sarcolemmal cholesterol content on intracellular calcium ion concentration in cultured cardiomyocytes;Bastiaanse;Arch Biochem Biophys,1994
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment–Elevation Myocardial Infarction: Results of REAL-TIMI 63B;Circulation;2022-09-20
2. MiR-145-5p modulates lipid metabolism and M2 macrophage polarization by targeting PAK7 and regulating β-catenin signaling in hyperlipidemia;Canadian Journal of Physiology and Pharmacology;2021-09
3. MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport;Journal of the American Heart Association;2021-07-06
4. miR155 Deficiency Reduces Myofibroblast Density but Fails to Improve Cardiac Function after Myocardial Infarction in Dyslipidemic Mouse Model;International Journal of Molecular Sciences;2021-05-22
5. Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design;European Heart Journal - Cardiovascular Pharmacotherapy;2021-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3